Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Kang Zhou

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2025
circNMD: A novel gene silencing mechanismJian-Kang Zhou, Yong Peng
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|February 18, 2012
[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B]Jia-Liang Tang, Jian-Kang Zhou
Cellular and Molecular Life Sciences : CMLS|April 4, 2023
circPTPN14 promotes renal fibrosis through its interaction with FUBP1 to enhance MYC transcriptionJian-Kang Zhou, Jiao Li, Yong Peng
Cell Stress|August 16, 2021
PDLIM1: Structure, function and implication in cancerJian-Kang Zhou, Xin Fan, Jian Cheng, et al.
Molecular Cancer|April 17, 2020
The role of long noncoding RNAs in hepatocellular carcinomaZhao Huang, Jian-Kang Zhou, Yong Peng, et al.
Precision Clinical Medicine|December 25, 2025
RNA modifications in health and disease: from mechanistic insights to therapeutic applicationsYiting Chen, Dulin Ding, Xing Tang, et al.
Oncotarget|October 27, 2017
Profiling and bioinformatic analysis of circular RNA expression regulated by c-MycQiheng Gou, Ke Wu, Jian-Kang Zhou, et al.
Cell Communication and Signaling : CCS|November 11, 2025
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancerHongyu Pan, Xinyu Wu, Bingshuang Hu, et al.
Cancer Communications (London, England)|January 14, 2021
CircBA1 derived from BCR-ABL fusion gene inhibits cell proliferation in chronic myeloid leukemiaJin Wang, Hu-Lin Ma, Wen-Rong Liu, et al.
Bioorganic & Medicinal Chemistry|April 28, 2019
Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesisXin Fan, Huaiyu He, Jiao Li, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2025
circNMD: A novel gene silencing mechanismJian-Kang Zhou, Yong Peng
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|February 18, 2012
[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B]Jia-Liang Tang, Jian-Kang Zhou
Cellular and Molecular Life Sciences : CMLS|April 4, 2023
circPTPN14 promotes renal fibrosis through its interaction with FUBP1 to enhance MYC transcriptionJian-Kang Zhou, Jiao Li, Yong Peng
Cell Stress|August 16, 2021
PDLIM1: Structure, function and implication in cancerJian-Kang Zhou, Xin Fan, Jian Cheng, et al.
Molecular Cancer|April 17, 2020
The role of long noncoding RNAs in hepatocellular carcinomaZhao Huang, Jian-Kang Zhou, Yong Peng, et al.
Precision Clinical Medicine|December 25, 2025
RNA modifications in health and disease: from mechanistic insights to therapeutic applicationsYiting Chen, Dulin Ding, Xing Tang, et al.
Oncotarget|October 27, 2017
Profiling and bioinformatic analysis of circular RNA expression regulated by c-MycQiheng Gou, Ke Wu, Jian-Kang Zhou, et al.
Cell Communication and Signaling : CCS|November 11, 2025
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancerHongyu Pan, Xinyu Wu, Bingshuang Hu, et al.
Cancer Communications (London, England)|January 14, 2021
CircBA1 derived from BCR-ABL fusion gene inhibits cell proliferation in chronic myeloid leukemiaJin Wang, Hu-Lin Ma, Wen-Rong Liu, et al.
Bioorganic & Medicinal Chemistry|April 28, 2019
Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesisXin Fan, Huaiyu He, Jiao Li, et al.
Pageof 4